These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 25342145
1. High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses. Mudhasani R, Kota KP, Retterer C, Tran JP, Tritsch SR, Zamani R, Whitehouse CA, Bavari S. J Biomol Screen; 2015 Jan; 20(1):141-52. PubMed ID: 25342145 [Abstract] [Full Text] [Related]
2. High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses. Mudhasani R, Kota KP, Retterer C, Tran JP, Whitehouse CA, Bavari S. PLoS Negl Trop Dis; 2014 Aug; 8(8):e3095. PubMed ID: 25144302 [Abstract] [Full Text] [Related]
3. High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection. Islam MK, Baudin M, Eriksson J, Öberg C, Habjan M, Weber F, Överby AK, Ahlm C, Evander M. J Biomol Screen; 2016 Apr; 21(4):354-62. PubMed ID: 26762502 [Abstract] [Full Text] [Related]
4. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign. Smith TM, Lim SP, Yue K, Busby SA, Arora R, Seh CC, Wright SK, Nutiu R, Niyomrattanakit P, Wan KF, Beer D, Shi PY, Benson TE. J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731 [Abstract] [Full Text] [Related]
5. New Highly Selective Antivirals for Chikungunya Virus identified from the Screening of a Drug-Like Compound Library. Castro EF, Álvarez DE. Curr Microbiol; 2024 Sep 04; 81(10):343. PubMed ID: 39227496 [Abstract] [Full Text] [Related]
6. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS, Wu KX, Chen KC, Ng MM, Chu JJ. Antivir Ther; 2011 Sep 04; 16(8):1203-18. PubMed ID: 22155902 [Abstract] [Full Text] [Related]
7. A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2. Lucas-Hourani M, Lupan A, Desprès P, Thoret S, Pamlard O, Dubois J, Guillou C, Tangy F, Vidalain PO, Munier-Lehmann H. J Biomol Screen; 2013 Feb 04; 18(2):172-9. PubMed ID: 22983165 [Abstract] [Full Text] [Related]
8. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Adcock RS, Chu YK, Golden JE, Chung DH. Antiviral Res; 2017 Feb 04; 138():47-56. PubMed ID: 27919709 [Abstract] [Full Text] [Related]
9. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. Delang L, Segura Guerrero N, Tas A, Quérat G, Pastorino B, Froeyen M, Dallmeier K, Jochmans D, Herdewijn P, Bello F, Snijder EJ, de Lamballerie X, Martina B, Neyts J, van Hemert MJ, Leyssen P. J Antimicrob Chemother; 2014 Oct 04; 69(10):2770-84. PubMed ID: 24951535 [Abstract] [Full Text] [Related]
15. The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products. Delekta PC, Raveh A, Larsen MJ, Schultz PJ, Tamayo-Castillo G, Sherman DH, Miller DJ. J Biomol Screen; 2015 Jun 04; 20(5):673-80. PubMed ID: 25550354 [Abstract] [Full Text] [Related]
17. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle. Gardner TJ, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella D. Antiviral Res; 2015 Jan 04; 113():49-61. PubMed ID: 25446405 [Abstract] [Full Text] [Related]
19. Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening. Zhang J, Liu T, Tong X, Li G, Yan J, Ye X. Antiviral Res; 2012 Jan 04; 93(1):48-54. PubMed ID: 22057306 [Abstract] [Full Text] [Related]